Brazil’s Fight against Hepatitis C — Universalism, Local Production, and Patents

Elbasvir/Grazoprevir: A Review of the Latest Agent in the Fight against Hepatitis C

Hepatitis C virus (HCV) is estimated to affect up to 150 million people worldwide. Despite worldwide prevalence, treatment modalities prior to 2011 remained suboptimal, with low virologic response rates and intolerable side effect profiles. Fortunately, the landscape of treatment for chronic hepatitis C has rapidly evolved since the introduction of HCV NS3/4 protease inhibitors in 2011. Elbasvi...

The Case Against Patents

Fight against pneumonia.

Recently, WHO has decided to launch an annual “World Pneumonia Day” on November 2, 2009(1). The day will mobilize efforts to fight pneumonia, rightly called a ‘neglected’ or a ‘forgotten’ disease, that kills more than two million children under the age of five each year worldwide(2). The sudden shift of focus on pneumonia has raised many eyebrows and brought forward few issues that need clarifi...

The Fight against Poliomyelitis

The Fight against Poliomyelitis